Tools
Tools
Lee, Cecilia S, Kim, Alisa J, Baughman, Douglas, Egan, Catherine, Bailey, Clare, Johnston, Robert L, Natha, Salim, Khan, Rehna, Brand, Christopher, Akerele, Toks, McKibbin, Martin, Downey, Louise, Al-Husainy, Saher, Lee, Aaron Y and Tufail, Adnan (2018) VISUAL ACUITY IMPROVEMENT WHEN SWITCHING FROM RANIBIZUMAB TO AFLIBERCEPT IS NOT SUSTAINED. Retina (Philadelphia, Pa.), 38 (5). pp. 951-956. ISSN 1539-2864. This article is available to all HEFT staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their HEFT Athens login IDs
Full text not available from this repository.Abstract
PURPOSE
To assess whether visual benefits exist in switching to aflibercept in patients who have been chronically treated with ranibizumab for neovascular age-related macular degeneration.
METHODS
A multicenter, national, electronic medical record database study was performed. Patients undergoing six continuous monthly ranibizumab injections and then switched to continuous aflibercept were matched to those on continuous ranibizumab therapy. Matching was performed in a 2:1 ratio and based on visual acuity 6 months before and at the time of the switch, and the number of previous ranibizumab injections.
RESULTS
Patients who were switched to aflibercept demonstrated transiently significant improvement in visual acuity that peaked at an increase of 0.9 Early Treatment Diabetic Retinopathy Study letters 3 months after the switch, whereas control patients continued on ranibizumab treatment showed a steady decline in visual acuity. Visual acuity differences between the groups were significant (P < 0.05) at 2, 3, and 5 months after the switch. Beginning at 4 months after the switch, the switch group showed a visual acuity decline similar to the control group.
CONCLUSION
Transient, nonsustained improvement in visual acuity occurs when switching between anti-vascular endothelial growth factor agents, which may have implications in treating patients on chronic maintenance therapy on one anti-vascular endothelial growth factor medication.
| Item Type: | Article |
|---|---|
| Additional Information: | This article is available to all HEFT staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their HEFT Athens login IDs |
| Subjects: | WW Eyes. Ophthalmology |
| Divisions: | Ambulatory Care > Ophthalmology |
| Related URLs: | |
| Depositing User: | Mrs Semanti Chakraborty |
| Date Deposited: | 16 Jul 2018 15:53 |
| Last Modified: | 16 Jul 2018 15:53 |
| URI: | http://www.repository.uhblibrary.co.uk/id/eprint/1698 |
Actions (login required)
 |
View Item |
